Results 81 to 90 of about 22,928 (253)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw

open access: yesBiomedical Papers, 2015
Aim: This article covers the authors' experience with the treatment of bisphosphonate-related osteonecrosis of the jaw in 11 individuals. Methods: A retrospective study of patients diagnosed and treated for bisphosphonate-related osteonecrosis of the jaw
Zuzana Janovska   +2 more
doaj   +1 more source

Exploring Perimenopausal and Menopausal Women's Oral Health Perceptions and Practices in Australia—A Qualitative Study

open access: yesGerodontology, EarlyView.
ABSTRACT Objective To explore the perceptions and practices of women in peri/menopause towards oral healthcare in Australia. Background Hormonal changes associated with peri/menopause create a period where women may be more prone to developing oral health problems, which can significantly impact their quality of life.
Namitha Thomas   +4 more
wiley   +1 more source

Platelet Rich Plasma in the Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw: Personal Experience and Review of the Literature

open access: yesInternational Journal of Dentistry, 2014
Bisphosphonates (BPs) are a class of synthetic drugs commonly used to treat bone metastasis and various bone diseases that cause osseous fragility (such as osteoporosis). Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a common complication in
F. Longo   +6 more
doaj   +1 more source

Fatal infectious encephalitis as a complication of medication-related osteonecrosis of the jaw

open access: yesOral and Maxillofacial Surgery Cases, 2020
We present a unique case of bacterial encephalitis in a 79-year-old female due to progression of medication-related osteonecrosis of the jaw. The occurrence of this life-threatening neurologic condition following the expansion of medication-related ...
Hye-Won Kim   +3 more
doaj   +1 more source

Medication-Related Osteonecrosis of the Jaws

open access: yesJNCI Monographs, 2019
AbstractMedication-related osteonecrosis of the jaw is an oral complication in cancer patients being treated with either antiresorptive or antiangiogenic drugs. The first reports of MRONJ were published in 2003. Hundreds of manuscripts have been published in the medical and dental literature describing the complication, clinical and radiographic signs ...
Cesar A, Migliorati   +2 more
openaire   +2 more sources

Recommendations for bone‐directed therapy in patients with neuroendocrine tumour skeletal metastases at the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting

open access: yesInternal Medicine Journal, EarlyView.
Abstract The role of anti‐resorptive agents in patients with bone metastases from neuroendocrine neoplasms is unclear. Our aim was to review bone‐specific treatment recommendations by the New Zealand National Neuroendocrine Tumour Multidisciplinary Meeting (MDM).
Gayle Radley   +3 more
wiley   +1 more source

Effects of Preoperative Drug Holiday On Sequester Separation and Treatment Outcome in Cancer Patients With Medication-Related Osteonecrosis of The Jaw [PDF]

open access: green, 2021
Mitsunobu Otsuru   +9 more
openalex   +1 more source

Comments on "diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus" [PDF]

open access: yes, 2015
Letter to ...
Assaf   +39 more
core   +1 more source

Systemic, Lifestyle and Environmental Modifying Factors in the Pathogenesis of Periodontitis

open access: yesJournal of Periodontal Research, EarlyView.
A variety of impacting factors in the pathogenesis of periodontitis exist, including systemic, lifestyle, and environmental factors. This review highlights the manifold mechanistic aspects of the link between the pathogenesis of periodontitis, addressing these numerous factors to supplement the long‐standing knowledge of the progression of the disease.
Groeger Sabine Elisabeth   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy